文献
J-GLOBAL ID:201902236038410819
整理番号:19A0176825
炎症性疾患の治療のための強力で選択的なRIPK2阻害剤の同定【JST・京大機械翻訳】
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases
著者 (30件):
He Xiaohui
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Da Ros Sara
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Nelson John
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Zhu Xuefeng
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Jiang Tao
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Okram Barun
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Jiang Songchun
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Michellys Pierre-Yves
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Iskandar Maya
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Espinola Sheryll
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Jia Yong
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Bursulaya Badry
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Kreusch Andreas
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Gao Mu-Yun
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Spraggon Glen
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Baaten Janine
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Clemmer Leah
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Meeusen Shelly
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Huang David
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Hill Robert
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Nguyen-Tran Van
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Fathman John
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Liu Bo
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Tuntland Tove
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Gordon Perry
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Hollenbeck Thomas
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Ng Kenneth
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Shi Jian
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Bordone Laura
(Genomics Institute of the Novartis Research Foundation, California, United States)
,
Liu Hong
(Genomics Institute of the Novartis Research Foundation, California, United States)
資料名:
ACS Medicinal Chemistry Letters
(ACS Medicinal Chemistry Letters)
巻:
8
号:
10
ページ:
1048-1053
発行年:
2017年
JST資料番号:
W5043A
ISSN:
1948-5875
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)